Press Releases<< Back
100,000th AlloMap Result Provided to Heart Transplant Patients
The increasing use of AlloMap contributes to this milestone. More than 90% of US heart transplant centers are now using the guideline-recommended AlloMap for heart transplant patient surveillance. "AlloMap has become a standard of care to monitor heart transplant patients for probability of rejection," said
For more information, please visit: www.CareDx.com.
Forward Looking Statements
This press release contains forward-looking statements about our business, research, development and commercialization efforts including, but not limited to the development, commercialization, utility, performance and adoption of AlloSure. These forward-looking statements are based upon information that is currently available to us and our current expectations, speak only as of the date hereof, and are subject to numerous risks and uncertainties, including risk associated with successful research, development and planned commercialization of our technologies, that are described in our filings with the
Sasha King, Chief Commercial Officer T: +1 415-287-2393 E: email@example.com
News Provided by Acquire Media